참고문헌
- Gourdie RG, Dimmeler S and Kohl P (2016) Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov 15, 620-638 https://doi.org/10.1038/nrd.2016.89
- Furtado MB, Nim HT, Boyd SE and Rosenthal NA (2016) View from the heart: cardiac fibroblasts in development, scarring and regeneration. Development 143, 387-397 https://doi.org/10.1242/dev.120576
- Ho CY, Lopez B, Coelho-Filho OR et al (2010) Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 363, 552-563 https://doi.org/10.1056/NEJMoa1002659
- Piera-Velazquez S, Li Z and Jimenez SA (2011) Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179, 1074-1080 https://doi.org/10.1016/j.ajpath.2011.06.001
- Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M and Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19, 2282-2287 https://doi.org/10.1681/ASN.2008050513
- Zeisberg EM, Tarnavski O, Zeisberg M et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952-961 https://doi.org/10.1038/nm1613
- Li Y, Lui KO and Zhou B (2018) Reassessing endothelialto- mesenchymal transition in cardiovascular diseases. Nat Rev Cardiol 15, 445-456 https://doi.org/10.1038/s41569-018-0023-y
- Zhan Y, Brown C, Maynard E et al (2005) Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 115, 2508-2516 https://doi.org/10.1172/JCI24403
- Hao G, Han Z, Meng Z et al (2015) Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis. Int J Clin Exp Pathol 8, 10216-10227
- Ye M, Coldren C, Liang X et al (2010) Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet 19, 648-656 https://doi.org/10.1093/hmg/ddp532
- Li C, Wang Z, Chen Y et al (2015) Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells. Oncol Rep 33, 559-565 https://doi.org/10.3892/or.2014.3613
- Shirakihara T, Saitoh M and Miyazono K (2007) Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell 18, 3533-3544 https://doi.org/10.1091/mbc.e07-03-0249
- Okano K, Hibi A, Miyaoka T et al (2012) Inhibitory effects of the transcription factor Ets-1 on the expression of type I collagen in TGF-beta1-stimulated renal epithelial cells. Mol Cell Biochem 369, 247-254 https://doi.org/10.1007/s11010-012-1388-6
- Wei WY, Zhang N, Li LL et al (2018) Pioglitazone alleviates cardiac fibrosis and inhibits endothelial to mesenchymal transition induced by pressure overload. Cell Physiol Biochem 45, 26-36 https://doi.org/10.1159/000486220
- Koinuma D, Tsutsumi S, Kamimura N et al (2009) Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling. Mol Cell Biol 29, 172-186 https://doi.org/10.1128/MCB.01038-08
- Czuwara-Ladykowska J, Sementchenko VI, Watson DK and Trojanowska M (2002) Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J Biol Chem 277, 20399-20408 https://doi.org/10.1074/jbc.M200206200
- Millien G, Cao Y, O'Hara CJ et al (2018) ETS1 regulates Twist1 transcription in a Kras (G12D) /Lkb1(-/-) metastatic lung tumor model of non-small cell lung cancer. Clin Exp Metastasis 35, 149-165 https://doi.org/10.1007/s10585-018-9912-z
- Sinh ND, Endo K, Miyazawa K and Saitoh M (2017) Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells. Cancer Sci 108, 952-960 https://doi.org/10.1111/cas.13214
- Dave N, Guaita-Esteruelas S, Gutarra S et al (2011) Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem 286, 12024-12032 https://doi.org/10.1074/jbc.M110.168625
- Ye M, Parente F, Li X, Perryman MB et al (2014) Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects. Am J Med Genet A 164A, 966-974
- Sheng LJ, Ruan CC, Ma Y et al (2016) Beta3 adrenergic receptor is involved in vascular injury in deoxycorticosterone acetate-salt hypertensive mice. FEBS Lett 590, 769-778 https://doi.org/10.1002/1873-3468.12107
- Lin JR, Zheng YJ, Zhang ZB et al (2018) Suppression of endothelial-to-mesenchymal transition by SIRT (Sirtuin) 3 alleviated the development of hypertensive renal injury. Hypertension 72, 350-360 https://doi.org/10.1161/HYPERTENSIONAHA.118.10482
- He D, Jin J, Zheng Y, Bruce IC, Tam S and Ma X (2013) Anti-angiogenesis effect of trichosanthin and the underlying mechanism. Biochem Biophys Res Commun 430, 735-740 https://doi.org/10.1016/j.bbrc.2012.11.080
- Plotnik JP, Budka JA, Ferris MW and Hollenhorst PC (2014) ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells. Nucleic Acids Res 42, 11928-11940 https://doi.org/10.1093/nar/gku929